VAXXINITY INC - COMMON STK (VAXX)

CUSIP: 92244V104

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / COMMON STK
Total 13F shares
8,325,196
Share change
+2,879,404
Total reported value
$18,897,598
Price per share
$2.27
Number of holders
46
Value change
+$6,641,035
Number of buys
31
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 92244V104?
CUSIP 92244V104 identifies VAXX - VAXXINITY INC - COMMON STK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of VAXXINITY INC - COMMON STK (VAXX) as of Q1 2023

As of 31 Mar 2023, VAXXINITY INC - COMMON STK (VAXX) was held by 46 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,325,196 shares. The largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., BANK OF AMERICA CORP /DE/, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Creative Planning, MILLENNIUM MANAGEMENT LLC, SCOGGIN MANAGEMENT LP, and Qube Research & Technologies Ltd. This page lists 46 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.